ERT ANNOUNCES
COGSTATE
PARTNERSHIP

READ MORE Industry-leading cognitive assessments will now be available through ERT's eCOA Platform.

ERT ANNOUNCES
COGSTATE
PARTNERSHIP

Industry-leading cognitive assessments will now be available through ERT's eCOA Platform.

REINVENTING ENDPOINT
MEASUREMENT IN
CLINICAL TRIALS

LEARN MORE ERT Acquires APDM Wearable Technologies

VIRTUAL VISITS

LEARN MORE Find out how we can rapidly deploy Virtual Visit technology into your existing or upcoming clinical trial or post-approval study. Find out how we can rapidly deploy Virtual Visit technology into your existing or upcoming clinical trial or post-approval study.

VIRTUAL VISITS

A BETTER WAY TO
MANAGE YOUR
CLINICAL DEVELOPMENT

LEARN MORE Meet goals and achieve higher quality data, reduced costs, and shortened study timelines with support from ERT. Meet goals and achieve higher quality data, reduced costs, and shortened study timelines with support from ERT.

A BETTER WAY TO
MANAGE YOUR
CLINICAL DEVELOPMENT

5.2M+

Patients Enrolled

230K

Sites Supported

600+

Drug Approvals

15K

Trials Managed

a better way to manage your trials

Meet clinical development goals and achieve higher quality data, reduced costs, and shortened study timelines with support from ERT.

Deliver Your Vaccine Trials. Faster.

ERT speeds up your vaccine clinical studies, capturing patient data quickly and accurately with its dedicated vaccines ePRO solution.



MINIMIZE RISK AND UNCERTAINTY

We deliver the flexibility and adaptability you need to overcome challenges for faster speed to market. Here’s how:

230k investigative sites supported
Every trial runs into unexpected challenges. With more than 15,000 trials under our belt, we’ve seen them before and have the expertise to put your trial back on course with our predictive analytics.
25 ready-to-launch analytics tools
We protect  your trial before there’s ever an issue, ensuring its success through near real-time access to study, program and enterprise-level performance.

NEWS & EVENTS

LATEST NEWS

What does CNS Endpoint Measurement have in Common with the Fosbury Flop?

Learn how clinical trial sponsors can raise the bar in developing more effective treatments for movement disorders by using high precision wearables and digital biomarkers to reinvent endpoint measurement.

FDA Guidance Overview: Assessing Symptoms in Clinical Trials Aimed to Prevent and Treat COVID-19

Learn the FDA’s position on assessing symptoms in clinical trials of drugs and biologics for the prevention and treatment of COVID-19.


What Clinical Trial Assessments Can Be Done Virtually?

Understand the options for performing clinical trials using virtual research tools and technologies, and how these changes will impact clinical research in the years to come.